Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic
oleh: Javier Díez, Antoni Bayes‐Genis
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2017-10-01 |
Deskripsi
Subjek
Editorials; biomarker; myocardial infarction; non–ST‐segment elevation acute coronary syndrome; risk stratification; ST‐segment elevation myocardial infarction